1. HBW Insight
  2. >>Geography
  3. >>Europe

Stada Says Lemocin’s OTC Status 'Vindicated' By German Switch Committee Decision

 
• By David Ridley

Stada's Lemocin cough lozenges survive a German reverse-switch threat, as does first generation anti-histamine dimenhydrinate, pointing to possible good news for the company's other major German OTC brand, Hoggar Night (doxylamine), which is also having its OTC status re-examined by the country's Expert Committee on Prescription.

A U turn arrow traffic symbol imprint on a lonely asphalt road against a blue cloudy sky. - Image
• Source: Shutterstock

German consumers will continue to be able to buy Stada Arzneimittel’s popular sore throat lozenge Lemocin without a prescription thanks to a decision by the country’s Expert Committee on Prescription (SVA) not to recommend the reverse-switch of its active ingredient tyrothricin.

"We feel vindicated by the SVA's recommendation and are pleased to be able to continue to offer patients Lemocin, a safe and well-tolerated medicine for the treatment of sore throats that has been tried and tested for decades, over

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography